Upgrade to SI Premium - Free Trial

AnaptysBio (ANAB) PT Raised to $66 at Leerink Partners

April 24, 2026 7:19 AM
Leerink Partners analyst David Risinger raised the price target on AnaptysBio (NASDAQ: ANAB) to $66.00 (from $64.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change